1. Provide training on these Guidelines. | |
 2. Develop case studies of how patient advocacy organizations have worked with the biopharmaceutical industry in the past. | |
 3. Trade patient-friendly toolkits with other patient advocacy organizations. | |
 4. Provide education and guidance to patients concerning: | |
  ○ Clinical trial participation; informed consent and how to make a decision about participating in a clinical trial | |
  ○ The use of social media around clinical trials | |
  ○ How patients should interact with industry regarding participation in advisory groups | |
 5. Provide education for academic researchers about how to communicate information about clinical trials with patients. |